ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,140Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 19

$549K Total Retail Price of All Prescriptions

Rank: 6 out of 19

244 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 244 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

36% of this provider’s 244 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 39.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 473 401 S3 1 1
FUROSEMIDE 366 321 2 2
AMLODIPINE BESYLATE 294 250 3 3
GABAPENTIN 284 219 4 12
LEVOTHYROXINE SODIUM 278 239 5 4
OMEPRAZOLE 253 244 6 5
METOPROLOL TARTRATE 246 225 7 13
SIMVASTATIN 237 210 8 7
CITALOPRAM HBR 230 166 9 15
LISINOPRIL 214 175 10 6
DONEPEZIL HCL 208 188 11 9
MIRTAZAPINE 208 203 11 14
RANITIDINE HCL 207 173 13 17
WARFARIN SODIUM 204 110 14 10
RISPERIDONE 180 179 15 18
SERTRALINE HCL 180 168 15 25
POTASSIUM CHLORIDE 169 148 17 11
NAMENDA 161 146 18 8
DIVALPROEX SODIUM 146 111 19 27
CARVEDILOL 141 82 20 23
PLAVIX 116 90 21 39
FAMOTIDINE 112 85 22 31
PRAVASTATIN SODIUM 105 56 23 32
NOVOLIN R 101 79 24 47
CLONIDINE HCL 99 84 25 56
NITROGLYCERIN PATCH 91 83 26 74
ESCITALOPRAM OXALATE 89 89 27 21
CLOPIDOGREL 81 65 28 30
TRAZODONE HCL 80 75 29 20
LEVEMIR 75 48 30 110
METFORMIN HCL 74 60 31 26
POLYETHYLENE GLYCOL 3350 72 69 32 51
ISOSORBIDE MONONITRATE ER 71 59 33 42
QUETIAPINE FUMARATE 67 65 34 22
ALBUTEROL SULFATE 67 57 34 19
TRAMADOL HCL 66 62 36 16
SEROQUEL 63 52 37 48
LANTUS 62 51 38 29
LOSARTAN POTASSIUM 61 43 39 43
DIGOXIN 61 47 39 40
HYDRALAZINE HCL 60 48 41 58
GLIPIZIDE ER 59 59 42 104
LEXAPRO 56 56 43 44
CYMBALTA 56 44 43 52
PAROXETINE HCL 54 36 45 88
TAMSULOSIN HCL 51 38 46 35
VENLAFAXINE HCL 50 34 47 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.